Post-marketing safety surveillance monitoring of RSV vaccines including Bancel's MODERNA mRNA RSV vaccine revealed serious adverse outcomes begging the question, why has FDA left these on market?
Substack vax - Trending on BuzzSumo 2025-09-08
Summary:
Post-marketing safety surveillance monitoring of RSV vaccines including Bancel's MODERNA mRNA RSV vaccine revealed serious adverse outcomes begging the question, why has FDA left these on market? substack.com